• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forum Guidelines

International Alliance of ALS/MND Associations › Forums › Member Forum › Forum Guidelines

  • This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by Admin.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • August 15, 2016 at 9:48 am #2059
    Admin
    Keymaster

      While writing on the forum, we expect all members to treat one another with respect, even if we may disagree. Our Executive Director will moderate the forum to the best of her ability. Please alert Cathy (alliance@als-mnd.org) if anyone is misusing the forum. We hope this is a wonderful resource for all of our members.

      • This topic was modified 6 years, 3 months ago by International Alliance.
      • This topic was modified 6 years, 3 months ago by Admin.
    • Author
      Posts
    Viewing 1 post (of 1 total)
    • You must be logged in to reply to this topic.
    Log In

    Primary Sidebar

    • Brigitte Wernli, Switzerland

      Brigitte Wernli, Switzerland

    • John Sweeney, USA

      John Sweeney, USA

    • Feng Gin Sun, China

      Feng Gin Sun, China

    • Alberto Baez Murillo, Colombia

      Alberto Baez Murillo, Colombia

    • Bruno Leanza Mantegna, Italy

      Bruno Leanza Mantegna, Italy

    • Angie Bordaen, Belgium

      Angie Bordaen, Belgium

    • Orly Dichoso, Canada

      Orly Dichoso, Canada

    • Richard Clark, New Zealand

      Richard Clark, New Zealand

    • Jette Odgaard Villemoes, Denmark

      Jette Odgaard Villemoes, Denmark

    • Orlando Ruiz, Colombia

      Orlando Ruiz, Colombia

    • Ann Nicol, USA

      Ann Nicol, USA

    • Kirsty Gerlach, New Zealand

      Kirsty Gerlach, New Zealand

    • Maurice LeClerc, Canada

      Maurice LeClerc, Canada

    • Ali Var, Turkey

      Ali Var, Turkey

    • Christian Bär, Germany

      Christian Bär, Germany

    • Seckin McGuirk, England

      Seckin McGuirk, England

    • Guido De Mets, Belgium

      Guido De Mets, Belgium

    • Bob Simonds, USA

      Bob Simonds, USA

    • Chih Ching Darren Wong, Malaysia

      Chih Ching Darren Wong, Malaysia

    • Michael Lee, Australia

      Michael Lee, Australia

    • Mauril Bélanger, Canada

      Mauril Bélanger, Canada

    • Willi Klein, UK

      Willi Klein, UK

    • Jorge Luis Fernández Romero, Mexico

      Jorge Luis Fernández Romero, Mexico

    • Yannick Richard, Canada

      Yannick Richard, Canada
      yannickrichard

    • Liong Ting Ngu, Malaysia

      Liong Ting Ngu, Malaysia

    • Philip Brindle, England

      Philip Brindle, England

    • Aida Trzmiel de Guterman, Argentina

      Aida Trzmiel de Guterman, Argentina

    • Shaleen Latchman, Canada

      Shaleen Latchman, Canada

    • Josée Kolijn-de Man, Netherlands

      Josée Kolijn-de Man, Netherlands

    • Laurie Petit-Jean, France

      Laurie Petit-Jean, France

    • Enzo Maccarrone, Italy

      Enzo Maccarrone, Italy

    • Claire Garry, USA

      Claire Garry, USA
      20200117_214643

    • Ailsa Malcolm-Hutton, UK

      Ailsa Malcolm-Hutton, UK

    • Valdomiro Xavier Honório, Brazil

      Valdomiro Xavier Honório, Brazil

    • Fabio Carvalho, Brazil

      Fabio Carvalho, Brazil

    • Susan Anderson, USA

      Susan Anderson, USA

    • Leon Ryba, Argentina

      Leon Ryba, Argentina

    • Kris Van Reusel, Belgium

      Kris Van Reusel, Belgium

    • Murat Morali, Turkey

      Murat Morali, Turkey

    • Malcolm Buck, Australia

      Malcolm Buck, Australia

    • Maria Lucia Wood Saldanha, Brazil

      Maria Lucia Wood Saldanha, Brazil

    • Karl Hughes, Ireland

      Karl Hughes, Ireland

    • Luis Antonio Pimenta Lima, Brazil

      Luis Antonio Pimenta Lima, Brazil

    • Sanjay Kumar Srivastava, India

      Sanjay Kumar Srivastava, India

    • Claudia Gotti, Brazil

      Claudia Gotti, Brazil

    • Amparo Muriel Engativa, Colombia

      Amparo Muriel Engativa, Colombia

    • Michel Perrozzo, France

      Michel Perrozzo, France

    • H. Todd Kelly, USA

      H. Todd Kelly, USA

    • Stephanie Christiansen Hall, Canada

      Stephanie Christiansen Hall, Canada

    • Hans Dieter Olszewski, Germany

      Hans Dieter Olszewski, Germany

    Learn more about the March of Faces

    Footer

    Stay connected to the global ALS/MND community.

    Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

     
    This field is for validation purposes and should be left unchanged.
    • Email
    • Facebook
    • LinkedIn
    • Twitter
    • YouTube
    Return to top of page

    Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

    Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


    Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login